Acadia Pharmaceuticals Inc. (ACAD)

[IanFromSI]

Why do you waste your time on this board? It has less than 10th of the users that the biotech board has, and about 1000th of the posts that the biotech values board has.

Are you being compensated to spread disinformation?

Nuplazid significantly improves the quality of life for PDP patients that are nearing the end of their days. Getting rid of hallucinations and delusions, as well as curing MDD in about a third of the patients is just a fabulous benefit for the patients and their families.

Acadia delivered these benefits to PDP patients and their families. There’s a desperate need to deliver a similar set of benefits to the ADP patients.

That is the opposite of the Biogen fiasco. Biogen had 2 phase threes. One showed no benefits, the other failed miserably. The Adcom was almost unanimous in voting against approval.

When the FDA approved Aduhelm, 3 adcom members resigned in disgust.

This bears absolutely no resemblance to the approval process for Nuplazid whether we’re talking about PDP or ADP.

I don’t have the actual statistics, but I believe that Alzheimer’s disease progresses to death faster than PDP. The improved quality of life which Nuplazid would deliver is very much needed by this group of patients. I fully expect that Nuplazid will be approved for ADP and millions of families will benefit as a result.

But what do I know?

Ian